JOURNAL OF MOLECULAR RECOGNITION, published by Wiley, is an esteemed academic journal that has been at the forefront of molecular biology and structural biology research since its inception in 1988. With its ISSN 0952-3499 and E-ISSN 1099-1352, this journal serves as a vital platform for disseminating innovative studies and findings in the realms of biochemical interactions and molecular structure elucidation. Although currently positioned in Quartile 4 of both molecular and structural biology categories based on 2023 metrics, the journal is dedicated to advancing knowledge in quantitative and qualitative molecular recognition processes. Researchers, professionals, and students alike will find that this journal is instrumental in keeping abreast of cutting-edge developments in the field, even as it continues to build its impact and reputation within the dynamic research landscape. Located in the United Kingdom, it is committed to promoting a diverse range of studies that drive forward the understanding of molecular interaction phenomena, thus empowering its readership to contribute effectively to the field.

COMPUTERS IN BIOLOGY AND MEDICINE is a prestigious academic journal published by Pergamon-Elsevier Science Ltd, dedicated to advancing the fields of Computer Science Applications and Health Informatics. With an impressive impact factor and ranking within the Q1 quartile for both categories, this journal plays a crucial role in disseminating high-quality research findings that influence cutting-edge developments at the intersection of computing and healthcare. Covering a broad range of topics from computational biology to medical informatics, it serves as a vital resource for researchers, professionals, and students striving to harness technology for medical advancements. The journal has been publishing since 1970 and continues to evolve, incorporating the latest trends and innovations in the field, thereby ensuring that it remains a key contributor to scientific inquiry and knowledge. With accessible content and a global reach, COMPUTERS IN BIOLOGY AND MEDICINE invites submissions that elevate the understanding and application of computational methods in biological and medical contexts.

JOURNAL OF MOLECULAR MODELING, published by Springer, is a pivotal resource for researchers and professionals in the fields of chemistry, computer science, and molecular sciences. The journal's ISSN is 1610-2940, with an E-ISSN of 0948-5023, reflecting its commitment to disseminating cutting-edge research from 1996 to 2024. Although the journal does not operate under an Open Access model, it remains an invaluable platform for the publication of innovative studies related to computational methods, theoretical chemistry, and molecular simulations. With a notable categorization across multiple quartiles—including Q4 in Catalysis and Q3 in Computational Theory and Mathematics—the journal holds a distinct rank in Scopus, highlighting its influence and contribution to the discipline. The importance of this journal lies in its ability to bridge the gap between theoretical understanding and practical applications, making it essential reading for students and scholars seeking to advance their knowledge and research in molecular modeling.

Current Computer-Aided Drug Design, published by BENTHAM SCIENCE PUBL LTD, is a pivotal journal dedicated to the integration of computer-aided methodologies within the drug design process. With its ISSN 1573-4099 and E-ISSN 1875-6697, this journal serves as a vital resource for researchers, professionals, and students interested in advancing the fields of pharmacology and molecular medicine. Operating under a framework that spans from 2006 to 2024, it aims to foster innovative approaches and discussions surrounding drug design strategies, computational techniques, and the therapeutic potential of novel compounds. Although it currently holds a Q4 rating in Drug Discovery and Molecular Medicine as well as a Q3 in Medicine (miscellaneous) within the 2023 category quartiles, the journal continues to enhance its visibility and relevance in the academic community. Its Scopus rankings reflect its commitment to quality research, positioning it in the context of drug discovery and molecular studies. As the field of drug design evolves, Current Computer-Aided Drug Design remains an essential platform for disseminating cutting-edge findings and facilitating collaboration among specialists aiming for significant advancements in drug development.

Molecular Informatics is a prestigious journal published by WILEY-V C H VERLAG GMBH, dedicated to advancing the fields of computational analysis and molecular modeling. As a key resource in the realms of Computer Science Applications, Drug Discovery, Molecular Medicine, Organic Chemistry, and Structural Biology, this journal is recognized for its significant contributions and is ranked in the Q2 and Q3 categories across multiple disciplines, positioning it among the leading journals for researchers and academics. With an impressive track record since its inception in 2010 and converging its contributions until 2024, Molecular Informatics aims to bridge the gap between computational techniques and biological applications, promoting interdisciplinary collaboration and innovation. Accessible to a global audience, the journal reflects a commitment to advancing science through open access options, making cutting-edge research available to students, professionals, and decision-makers alike. This journal serves as an indispensable platform for disseminating high-quality research and fostering the development of new theoretical and practical frameworks in molecular informatics.

Wiley Interdisciplinary Reviews: Computational Molecular Science is a premier journal published by WILEY, dedicated to the intersection of computational techniques and molecular science. Boasting an impressive impact factor and consistently ranking in the Q1 category across several key disciplines including Biochemistry, Computational Mathematics, Computer Science Applications, Materials Chemistry, and Physical and Theoretical Chemistry, this journal plays a crucial role in disseminating high-quality research that bridges multiple fields. With its focus on providing a platform for interdisciplinary dialogue and innovative computational solutions, it serves as an essential resource for researchers, professionals, and students eager to push the boundaries of molecular science. While the journal does not currently offer open access, it remains a vital conduit for scholarly communication, fostering advancements in understanding molecular interactions through computational methods. The journal is based in the United States, contributing to its global outreach and impact in the scientific community.

Chemical Biology & Drug Design, an esteemed publication by WILEY, serves as a vital platform for the dissemination of pioneering research in the interdisciplinary fields of biochemistry, drug discovery, molecular medicine, organic chemistry, and pharmacology. With a dedicated commitment to advancing the understanding of chemical interactions and drug development, this journal not only fosters innovation but also bridges the gap between theoretical research and practical applications. It boasts an impressive impact factor and is recognized in the 2023 category quartiles as Q3 in Biochemistry and Molecular Medicine, and Q2 in Drug Discovery, Organic Chemistry, and Pharmacology, indicating its relevance and influence in these crucial areas. The journal’s rankings across various Scopus categories further solidify its position as a reputable resource for researchers, professionals, and students striving to stay at the forefront of medicinal chemistry and drug design. While primarily traditional access-based, the journal's evolving scope from 2006 to 2024 ensures an ongoing contribution to essential scientific dialogue, making it an indispensable read for those committed to advancing health sciences.

The Journal of Computational Biophysics and Chemistry, published by World Scientific Publishing Co. Pte Ltd, is a distinguished platform dedicated to advancing the fields of biophysics and computational chemistry. With an ISSN of 2737-4165 and an E-ISSN of 2737-4173, this journal has garnered attention since its inception, earning a Q3 ranking in Computational Theory and Mathematics and Q4 rankings in both Computer Science Applications and Physical and Theoretical Chemistry as of 2023. The scope of the journal encompasses innovative research that integrates computational techniques with biochemical applications, making it essential reading for researchers, professionals, and students alike. With open access options available, the journal ensures that cutting-edge findings are easily accessible to a global audience, thereby fostering collaboration and innovation in the scientific community. Based in Singapore, the journal aims to converge ideas and methodologies from 2021 to 2024, paving the way for transformative insights in computational methods. Join a community at the forefront of research and applications that bridge disciplines through rigorous scholarship and pioneering discoveries.

CURRENT TOPICS IN MEDICINAL CHEMISTRY is a prestigious journal published by Bentham Science Publishers Ltd, dedicated to advancing the field of medicinal chemistry through the dissemination of high-quality research from 2001 to 2024. With an ISSN of 1568-0266 and an E-ISSN of 1873-4294, this journal is recognized for its significant contributions, as evidenced by its Scopus ranking in the 63rd percentile in the category of Drug Discovery, specifically at position #58 out of 157. Currently placed in Quartile 3 within Drug Discovery and Quartile 2 in miscellaneous medicine as of 2023, it serves as an essential resource for researchers, professionals, and students interested in the latest developments, methodologies, and applications in medicinal chemistry. The journal aims to foster collaboration and innovation by featuring original research articles, reviews, and brief communications that address current and emerging challenges in the discipline. Although it is not an open access platform, the journal's rich content is indispensable for those striving to enhance therapeutic strategies and drug development processes.

Computational and Theoretical Chemistry, published by ELSEVIER, stands at the forefront of interdisciplinary research in the realms of computational chemistry, theoretical physics, and biochemistry. With its ISSN 2210-271X and E-ISSN 1872-7999, the journal has established a significant presence in the academic community since its inception. Covering innovative computational methodologies and theoretical advancements, it addresses critical issues in condensed matter physics and molecular biochemistry, providing a rich resource for scholars and industry professionals alike. The journal enjoys a respectable impact factor and ranks notably in several Scopus categories, making it a vital platform for disseminating high-quality research. It adopts an open-access model, facilitating wider readership and engagement, which is essential for fostering collaborative innovations in the scientific landscape. As it continues to evolve from 2011 to 2024, Computational and Theoretical Chemistry is committed to advancing knowledge and promoting insightful discussions within the scientific community.